Literature DB >> 25677707

The potential of probiotics to prevent Clostridium difficile infection.

Stephen J Allen1.   

Abstract

Exposure to antibiotics is the major risk factor for Clostridium difficile diarrhea (CDD), suggesting that impairment of colonization resistance due to depletion of the gut flora is a significant underlying disease susceptibility factor. Many properties of probiotic organisms indicate that they may be able to replenish the depleted gut flora and restore colonization resistance. However, despite numerous clinical trials, the evidence base for probiotics in the prevention of CDD remains weak. A recent large trial of a multistrain, high-dose probiotic did not show clear evidence of efficacy. The role of probiotics in the prevention of CDD remains unclear.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bifidobacteria; C difficile diarrhea; Lactobacilli; Probiotic; Saccharomyces boulardii

Mesh:

Substances:

Year:  2015        PMID: 25677707     DOI: 10.1016/j.idc.2014.11.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  12 in total

1.  Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.

Authors:  Alla Aroutcheva; Julie Auclair; Martin Frappier; Mathieu Millette; Karen Lolans; Danielle de Montigny; Serge Carrière; Stephen Sokalski; William E Trick; Robert A Weinstein
Journal:  Probiotics Antimicrob Proteins       Date:  2016-03       Impact factor: 4.609

Review 2.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

Review 3.  Breakthroughs in the treatment and prevention of Clostridium difficile infection.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-10       Impact factor: 46.802

Review 4.  Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.

Authors:  Fawziah Marra; Karen Ng
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 5.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

Review 6.  The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.

Authors:  Shahla Abdollahi-Roodsaz; Steven B Abramson; Jose U Scher
Journal:  Nat Rev Rheumatol       Date:  2016-06-03       Impact factor: 20.543

7.  Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort.

Authors:  Martha L Carvour; Shane L Wilder; Keenan L Ryan; Carla Walraven; Fares Qeadan; Meghan Brett; Kimberly Page
Journal:  Am J Infect Control       Date:  2018-09-08       Impact factor: 2.918

Review 8.  Invasive Fungal Infections Acquired from Contaminated Food or Nutritional Supplements: A Review of the Literature.

Authors:  Kaitlin Benedict; Tom M Chiller; Rajal K Mody
Journal:  Foodborne Pathog Dis       Date:  2016-04-13       Impact factor: 3.171

Review 9.  Microbiology and ecology are vitally important to premedical curricula.

Authors:  Val H Smith; Rebecca J Rubinstein; Serry Park; Libusha Kelly; Vanja Klepac-Ceraj
Journal:  Evol Med Public Health       Date:  2015-07-21

10.  Is there a value for probiotic supplements in gestational diabetes mellitus? A randomized clinical trial.

Authors:  Neda Dolatkhah; Majid Hajifaraji; Fatemeh Abbasalizadeh; Naser Aghamohammadzadeh; Yadollah Mehrabi; Mehran Mesgari Abbasi
Journal:  J Health Popul Nutr       Date:  2015-11-25       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.